GDPD3: A Protein That Stimulates Gastrin Production and Interacts with Cells

Target Name: GDPD3

NCBI ID: G79153

GDPD3

GDPD3: A Protein That Stimulates Gastrin Production and Interacts with Cells

GDPD3 (Gastrin-Dependent Peptide-3) is a protein that is expressed in various tissues throughout the body, including the brain, pancreas, and gastrointestinal tract. It is a 21-kDa glycoprotein that is composed of two chains, A and B. GDPD3 is characterized by its ability to stimulate the production of gastrin, a hormone that stimulates the production of stomach acid.

Gastrin is a 28-kDa protein that is composed of two chains, A and B. It is synthesized in the cells of the parietal cells of the stomach, and its main function is to stimulate the production of stomach acid. Gastrin contains a critical region that is responsible for its ability to stimulate the production of stomach acid. This region contains a specific amino acid called glutamic acid, which is important for the formation of gastrin peptides.

GDPD3 is able to stimulate the production of gastrin peptides because it contains a specific amino acid that is similar to glutamic acid. This amino acid is called cysteine, and it is located on chain A of GDPD3. Cysteine is a sulfur-containing amino acid that is important for the structure and function of proteins.

In addition to its ability to stimulate the production of gastrin peptides, GDPD3 is also characterized by its ability to interact with specific receptors on the surface of various cell types. This interaction with receptors is important for the function of GDPD3, and it is a potential target for drug development.

GDPD3 has been shown to be involved in a number of different biological processes in the body. For example, it is involved in the regulation of gastric acid secretion, and it has been shown to play a role in the development and progression of various diseases, including cancer.

In addition to its potential clinical applications, GDPD3 is also of interest to researchers because of its unique structure and biology. The team that first identified GDPD3 identified a number of unique features that set it apart from other proteins. For example, GDPD3 is one of the only proteins that is able to stimulate the production of gastrin peptides, and it is the only protein that has been shown to interact with specific receptors on the surface of various cell types.

Overall, GDPD3 is a protein that has the potential to be a drug target or biomarker. Its unique structure and biology, as well as its ability to interact with specific receptors on the surface of various cell types, make it an attractive candidate for further research and development. Further studies are needed to fully understand the function and biology of GDPD3, and to determine its potential as a drug target or biomarker.

Protein Name: Glycerophosphodiester Phosphodiesterase Domain Containing 3

Functions: Hydrolyzes lysoglycerophospholipids to produce lysophosphatidic acid (LPA) and the corresponding amines (PubMed:27637550). Shows a preference for 1-O-alkyl-sn-glycero-3-phosphocholine (lyso-PAF), lysophosphatidylcholine (lyso-PC) and N-acylethanolamine lysophospholipids (PubMed:27637550). Does not display glycerophosphodiester phosphodiesterase activity, since it cannot hydrolyze either glycerophosphoinositol or glycerophosphocholine

The "GDPD3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GDPD3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets